Pharmaceutical maker Jubilant Pharmova, wholly owned subsidiary Jubilant Pharma Limited, through one of its wholly owned subsidiaries, Jubilant HollisterStier General Partnership, will invest $76.6 million to expand capacity at its Contract Manufacturing Organization (CMO) Montreal, Canada facility. Jubilant will receive a more than $19 million loan from the...
Top Head & Shoulder Pattern, with downward Breakout.
Kindly read chart carefully. Trade details are for educational purpose, kindly refer to your financial advisor before initiating any trades. Feedback welcome. Thanks & Regards
JublPharama is forming falling wedge pattern. Wait for confirmation breakout
NSE:JUBLPHARMA Please note that we are not a SEBI Registered Investor Adviser/PMS/ Broking House. All the contents over here are for educational purposes only and are not investment advice or recommendations offered to any person(s) with respect to the purchase or sale of the stocks / futures and options. You are also requested to apply your prudence and...
NSE:JUBLPHARMA Please note that we are not a SEBI Registered Investor Adviser/PMS/ Broking House. All the contents over here are for educational purposes only and are not investment advice or recommendations offered to any person(s) with respect to the purchase or sale of the stocks / futures and options. You are also requested to apply your prudence and...
JUBLPHARMA: Price pushed to corner. Seems like Elliott descending triangle and price reached to corner. Its time to go up!
Expecting a potential upside of about 70%. They supply products and services to customers in over 85 countries. They have four manufacturing facilities in North America and two in India, coupled with Research and Development centres in North America and India. Additionally, they have a distribution network of more than 45 radiopharmacy in the United...
Buying Jubilant Pharmova 618/- , some companies don't need to check technicals as it's currently in dirt cheap valuation
Do your own analysis before investing According to me stocks now doing oneside rally towards 900/1000 target
Jubilant Pharma Buying on 632 , clear Breakout can seen . I am buying 632/-
This bearish Engulfing candle suggest a strong buy , I will buy on open
Jublpharma cmp-759.65 Entry-739.15 Sl-710.40 Target-776,815.15,854.25 & above
It seems Jubilant pharma is forming a head band shoulders pattern which is a sign of bearish
RSI above 50 Macd is bullish Above SMA 20 Company is decided to develop Oral form of Remediviser Enter above 800 Stop Loss 725 Target 885
One of the most undervalued Pharma companies Jubilant is close to an important support zone. Short term support + breakout retest while also coinciding with Fibo support in this support zone.. Loook for any bounce here around 640-650 to attempt to go long. SL below 635. Please note..go long only and only if there is a bounce..not before that..